Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $9.6450 (-8.92%) ($9.1300 - $10.6000) on Fri. Nov. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.83% (three month average) | RSI | 42 | Latest Price | $9.6450(-8.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -2.7% a day on average for past five trading days. | Weekly Trend | AUTL declines -3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) ARKG(12%) BLOK(12%) BNDX(12%) SKYY(12%) XBI(12%) | Factors Impacting AUTL price | AUTL will decline at least -1.915% in a week (0% probabilities). TBT(-8%) USO(-7%) VIXM(-6%) UNG(-6%) EDOC(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.915% (StdDev 3.83%) | Hourly BBV | -2.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.07(-88.91%) | Inflection Point | Yes | Resistance Level | $10.86 | 5 Day Moving Average | $10.28(-6.18%) | 10 Day Moving Average | $10.59(-8.92%) | 20 Day Moving Average | $10.86(-11.19%) | To recent high | -37.1% | To recent low | 0% | Market Cap | $504m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |